1. Cediranib affects tumor dissemination and prolongs the survival of mice bearing patient-derived ovarian cancer xenografts (EOC-PDX). (July 2016) Authors: Decio, A.; Cesca, M.; Bizzaro, F.; Bani, M.R.; Belotti, D.; Giavazzi, R. Journal: European journal of cancer Issue: Volume 61(2016)Supplement 1 Page Start: S112 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immunohistochemical Characterixation of Murine Sarcomas Arising at the Injection Site of Human Patient-derived Xenografts. (January 2020) Authors: Minoli, L.; Decio, A.; Damia, G.; Giavazzi, R.; Scanziani, E.; Castiglioni, V. Journal: Journal of comparative pathology Issue: Volume 174(2020) Page Start: 159 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PO-64 Targeting energetic metabolism as therapeutic approach in cancer. Issue 200 (April 2021) Authors: Moreira-Barbosa, C.; Decio, A.; Anastasia, A.; Brunelli, L.; Pastorelli, R.; Panini, N.; Lupi, M.; Bani, M.R.; Giavazzi, R.; Ghilardi, C. Journal: Thrombosis research Issue: Issue 200(2021)Supplement 1 Page Start: S52 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗